Wenjie Xiang

发表

Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2

Ji Liang, Lianqiang Xu, K. Lan, 2022, bioRxiv.

Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge

Xin Eric Wang, Qianyun Liu, K. Lan, 2023, Signal transduction and targeted therapy.